Skip to main content

False Misrepresentation Claim For Greenfield Filter Tossed

False Misrepresentation Claim For Greenfield Filter Tossed

False Misrepresentation Claim For Greenfield Filter Tossed

Introduction

In an order issued on January 23, 2019, Chief Judge David C. Nye of the U.S. District Court for the District of Idaho dismissed a fraudulent misrepresentation claim filed by a plaintiff against Boston Scientific Corporation, finding that she failed to plead her allegations with the particularity mentioned in Rule 9(b).

The order stated that the plaintiff did not make it clear to the jury that the BSC sales representative was responsible for misrepresenting the effectiveness and safety of the IVC filter to the plaintiff doctor and whether her doctor responded to the alleged misrepresentation. The plaintiff was implanted with a Greenfield filter by her doctor on December 23, 2009, to treat her recurrent DVT (deep vein thrombosis) episodes. In her lawsuit, the plaintiff alleged that Boston Scientific failed to reveal the health risks associated with the Greenfield filter to physicians and patients, while extensively promoting it as a useful product. She asserted that she was at an increased risk of suffering from serious complications such as constant pain in the abdomen, filter migration, fracture or breakage of the filter, tissue perforation, and other devastating side-effects due to the filter's long-term implant. In May 2007, the FDA recalled the Greenfield IVC Filter after reports indicated incidents of cardiac and pulmonary embolization as a potential side-effect.

Similar IVC filter cases filed against C.R. Bard and Davol are consolidated as a part of a multidistrict litigation (MDL No. 2641; In Re: Bard IVC Filters Products Liability Litigation) for coordinated pretrial proceedings, overlooked by Judge David G. Campbell, in the United States District Court District of Arizona.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!